Search Results for "Ondansetron Im"

21:51 EDT 31st August 2016 | BioPortfolio

Matching Channels


Matching News

Ondansetron Should Not Be First Choice for Nausea in Pregnancy

Ondansetron was associated with a low risk for birth defects in neonates who were exposed during the first trimester of pregnancy, and the incidence of cardiac malformations may be increased slightly....

Bekinda Ondansetron: Phase II started

Ondansetron for Pregnancy-Associated Nausea and Vomiting

First-trimester use seems safe, although data are still limited.

Midatech launches chemo side effect drug in the US

Drug delivery specialist Midatech (LON:MPTH) will commercially launch Zuplenz, its anti-vomiting drug for chemo and radiotherapy patients, in the US this week. Midatech acquired the treatment from G...

Weighing The Risks And Benefits Of A Drug Prescribed To Pregnant Women For Extreme Morning Sickness

A new study suggests that the drug ondansetron, sold as Zofran, does not increase the risk of birth defects when taken for severe nausea and vomiting during pregnancy.

Tracking down deadly bloodstream infection

The source of a potential deadly blood infection in more than 50 South American cancer patients has now been identified by researchers. All of the patients infected with S. Kiliense received ondansetr...

Study finds no evidence linking anti-nausea drug to birth defects

Women suffering from extreme morning sickness often take Zofran (ondansetron) to combat their debilitating nausea and vomiting. However, two studies have found that the drug may increase risk of heart...

Midatech launch treatment to reduce chemo-induced vomiting in the US

Midatech Pharma (NASDAQ: MTP) has the full commercial launch of Zuplenz (ondansetron) in the US. The drug is an oral soluble film to prevent post-operative, chemotherapy and radiation-induced nausea a...

Matching PubMed Articles

Effect of Intravenous Ondansetron on the QT Interval of Patients' Electrocardiograms.

Ondansetron improves the success of oral rehydration in children with gastroenteritis. In postoperative adults, ondansetron has been shown to prolong the corrected QT (QTc). The aim of the study was t...

Ondansetron in acute food protein-induced enterocolitis syndrome, a retrospective case-control study.

Therapy for moderate to severe acute food protein induced enterocolitis syndrome (FPIES) typically consists of intravenous fluids and corticosteroids (traditional therapy). Ondansetron has been sugges...

Intravenous Ondansetron and the QT Interval in Adult Emergency Department Patients: An Observational Study.

Ondansetron is known to cause QT interval prolongation, but this effect and clinical significance has not been prospectively studied in adult emergency department (ED) patients. The primary objective ...


Placebo-controlled Randomized Trial Evaluating Efficacy of Ondansetron in Children with Diarrhea and Vomiting: Critical Appraisal and Updated Meta-analysis: Pediatricians Viewpoint.

Search Whole site using Google

Quick Search
Advertisement Advertisement